Source: Health Canada shortage reports · Updated Aug 21, 2026
Entecavir has no current shortage reported in Canada. It has been in shortage before; the history is below.
An antiviral medication used to treat chronic hepatitis B infection.
Products affected
0 / 5
Reports on file
14
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
APO-ENTECAVIR
0.5MG · TABLET · APOTEX INC
DIN 02396955 · ended Aug 20, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP ENTECAVIR
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02467232 · ended Aug 4, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ENTECAVIR
0.5MG · TABLET · APOTEX INC
DIN 02396955 · ended Apr 9, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ENTECAVIR
0.5MG · TABLET · APOTEX INC
DIN 02396955 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-ENTECAVIR
0.5MG · TABLET · AURO PHARMA INC
DIN 02448777 · ended Aug 25, 2025 · Demand increase for the drug.
Resolved
APO-ENTECAVIR
0.5MG · TABLET · APOTEX INC
DIN 02396955 · ended Jun 15, 2023 · Disruption of the manufacture of the drug.
Resolved
PMS-ENTECAVIR
0.5MG · TABLET · PHARMASCIENCE INC
DIN 02430576 · ended Sep 12, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-ENTECAVIR
0.5MG · TABLET · APOTEX INC
DIN 02396955 · ended Jul 3, 2020 · Disruption of the manufacture of the drug.
Resolved
JAMP ENTECAVIR
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02467232 · ended Mar 15, 2020 · Disruption of the manufacture of the drug.
Resolved
APO-ENTECAVIR
0.5MG · TABLET · APOTEX INC
DIN 02396955 · ended May 10, 2019 · Disruption of the manufacture of the drug.
Resolved
PMS-ENTECAVIR
0.5MG · TABLET · PHARMASCIENCE INC
DIN 02430576 · ended Jun 26, 2018 · Disruption of the manufacture of the drug.
Resolved
PMS-ENTECAVIR
0.5MG · TABLET · PHARMASCIENCE INC
DIN 02430576 · ended Oct 17, 2017 · Disruption of the manufacture of the drug.
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Entecavir. Health Canada has 14 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Entecavir is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AF).
Recent changes
Aug 21, 2026
Shortage resolved
Aug 13, 2026
Estimated end date pushed back : Aug 21, 2026 → Sep 4, 2026
Aug 6, 2026
Estimated end date pushed back : Aug 7, 2026 → Aug 21, 2026
Aug 5, 2026
Shortage resolved
Jul 29, 2026
Estimated end date pushed back : Jul 24, 2026 → Aug 7, 2026
Jul 9, 2026
Estimated end date pushed back : Jul 24, 2026 → Aug 7, 2026
Common questions
What is Entecavir used for?
An antiviral medication used to treat chronic hepatitis B infection.
When will Entecavir be back in stock in Canada?
Entecavir has no active shortage; supply is normal per Health Canada reports.
Why is Entecavir in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.